Search results
Ranbaxy Laboratories Limited was an Indian multinational pharmaceutical company that was incorporated in India in 1961 and remained an entity until 2014. The company went public in 1973. Ownership of Ranbaxy changed twice over the course of its history.
Sun Pharma completed the acquisition of Ranbaxy Laboratories Limited, an integrated, research based, international pharmaceutical company, on 25th March 2015. Information and announcements about this can be found on this page.
Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) and Ranbaxy Laboratories Ltd (Reuters: RANB.BO, Bloomberg: RBXY IN, NSE: RANBAXY, BSE: 500359) today announced that they have entered into definitive agreements pursuant to which Sun Pharma will acquire 100% of Ranbaxy in an all-stock transaction.
Ranbaxy is a research based, international pharmaceutical company producing generic medicines and ranked 8th globally. It has a presence in 49 countries, a global alliance with Daiichi Sankyo, and a vision to achieve US $5 Bn sales by 2012.
Ranbaxy Laboratories Limited ialah syarikat farmaseutikal India yang ditubuhkan pada tahun 1961 dan tetap menjadi entiti hingga tahun 2014. Syarikat ini membuka penawaran pasaran awam pada tahun 1973. Pemilikan Ranbaxy berubah dua kali sepanjang sejarahnya.
Apr 7, 2014 · Sun Pharmaceutical Industries Ltd is buying Ranbaxy Laboratories Ltd through an all-stock merger in which five shares of Ranbaxy will fetch four shares of Sun Pharma. Based on their closing...
May 12, 2019 · An FDA inspection of this Ranbaxy facility in Toansa, Punjab, India, in 2014, revealed drug quality testing violations, resulting in the FDA prohibiting Ranbaxy from marketing drugs in the U.S...
